12-8863977-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_144670.6(A2ML1):​c.3686A>G​(p.His1229Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.994 in 1,612,776 control chromosomes in the GnomAD database, including 797,653 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1229C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.97 ( 71742 hom., cov: 31)
Exomes 𝑓: 1.0 ( 725911 hom. )

Consequence

A2ML1
NM_144670.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.46

Publications

21 publications found
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
A2ML1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.4597877E-6).
BP6
Variant 12-8863977-A-G is Benign according to our data. Variant chr12-8863977-A-G is described in ClinVar as Benign. ClinVar VariationId is 1169146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
A2ML1NM_144670.6 linkc.3686A>G p.His1229Arg missense_variant Exon 29 of 36 ENST00000299698.12 NP_653271.3 B3KVV6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
A2ML1ENST00000299698.12 linkc.3686A>G p.His1229Arg missense_variant Exon 29 of 36 1 NM_144670.6 ENSP00000299698.7 A8K2U0-1
A2ML1ENST00000541459.5 linkc.2336A>G p.His779Arg missense_variant Exon 18 of 25 2 ENSP00000443174.1 H0YGG5
A2ML1ENST00000539547.5 linkc.2213A>G p.His738Arg missense_variant Exon 18 of 25 2 ENSP00000438292.1 A8K2U0-2
ENSG00000282022ENST00000631830.1 linkn.322-5701T>C intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.970
AC:
147533
AN:
152160
Hom.:
71687
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.895
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.987
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.978
GnomAD2 exomes
AF:
0.993
AC:
247340
AN:
249146
AF XY:
0.995
show subpopulations
Gnomad AFR exome
AF:
0.896
Gnomad AMR exome
AF:
0.995
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.997
GnomAD4 exome
AF:
0.997
AC:
1455922
AN:
1460498
Hom.:
725911
Cov.:
55
AF XY:
0.997
AC XY:
724670
AN XY:
726558
show subpopulations
African (AFR)
AF:
0.890
AC:
29749
AN:
33442
American (AMR)
AF:
0.994
AC:
44471
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26136
AN:
26136
East Asian (EAS)
AF:
0.999
AC:
39645
AN:
39698
South Asian (SAS)
AF:
1.00
AC:
86143
AN:
86150
European-Finnish (FIN)
AF:
1.00
AC:
53405
AN:
53406
Middle Eastern (MID)
AF:
0.996
AC:
4751
AN:
4768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111758
AN:
1111914
Other (OTH)
AF:
0.993
AC:
59864
AN:
60260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
212
425
637
850
1062
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21658
43316
64974
86632
108290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.970
AC:
147649
AN:
152278
Hom.:
71742
Cov.:
31
AF XY:
0.971
AC XY:
72268
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.895
AC:
37175
AN:
41542
American (AMR)
AF:
0.987
AC:
15099
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3470
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5176
AN:
5178
South Asian (SAS)
AF:
1.00
AC:
4816
AN:
4818
European-Finnish (FIN)
AF:
1.00
AC:
10616
AN:
10616
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68022
AN:
68036
Other (OTH)
AF:
0.978
AC:
2069
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
221
443
664
886
1107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.991
Hom.:
126282
Bravo
AF:
0.965
TwinsUK
AF:
1.00
AC:
3708
ALSPAC
AF:
1.00
AC:
3854
ESP6500AA
AF:
0.901
AC:
3472
ESP6500EA
AF:
1.00
AC:
8248
ExAC
AF:
0.991
AC:
119721
Asia WGS
AF:
0.995
AC:
3460
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
7.9
DANN
Benign
0.85
DEOGEN2
Benign
0.0025
T;T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.026
T;T;T
MetaRNN
Benign
0.0000015
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-2.7
N;.;.
PhyloP100
1.5
PrimateAI
Benign
0.23
T
PROVEAN
Benign
1.6
N;N;N
REVEL
Benign
0.14
Sift
Benign
0.23
T;T;T
Sift4G
Benign
0.21
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.016
MPC
0.13
ClinPred
0.0071
T
GERP RS
-1.1
Varity_R
0.044
gMVP
0.31
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10219561; hg19: chr12-9016573; COSMIC: COSV55285955; COSMIC: COSV55285955; API